An overview of nosocomial infections, including the role of the microbiology laboratory
暂无分享,去创建一个
R. Gaynes | T. Emori | T G Emori | R P Gaynes
[1] D. Maki. Nosocomial bacteremia. An epidemiologic overview. , 1981, The American journal of medicine.
[2] A. Relman. Assessment and Accountability: The Third Revolution in Medical Care , 1991, The New England journal of medicine.
[3] R. Gaynes,et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. , 1991, The American journal of medicine.
[4] D. Maki,et al. Infection control in intravenous therapy. , 1973, Annals of internal medicine.
[5] Robert H. Brook,et al. Prospective Payment System and Impairment at Discharge , 1990 .
[6] R. Haley,et al. Techniques and uses of nosocomial infection surveillance in U.S. hospitals, 1976-1977. , 1981, The American journal of medicine.
[7] J. Mcgowan. New laboratory techniques for hospital infection control. , 1991, The American journal of medicine.
[8] W J Martone,et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. , 1992, American journal of infection control.
[9] F. Bérard,et al. POSTOPERATIVE WOUND INFECTIONS: THE INFLUENCE OF ULTRAVIOLET IRRADIATION OF THE OPERATING ROOM AND OF VARIOUS OTHER FACTORS. , 1964, Annals of surgery.
[10] W L Roper,et al. Effectiveness in health care. An initiative to evaluate and improve medical practice. , 1988, The New England journal of medicine.
[11] D Draper,et al. Comparing outcomes of care before and after implementation of the DRG-based prospective payment system. , 1990, JAMA.
[12] Nosocomial Infection Rates for Interhospital Comparison: Limitations and Possible Solutions , 1991, Infection Control & Hospital Epidemiology.
[13] Washington Ja nd,et al. Gentamicin-resistant Pseudomonas aeruginosa: Mayo Clinic Experience, 1970-1976. , 1977 .
[14] R. Weinstein,et al. Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance. , 1983, The Journal of antimicrobial chemotherapy.
[15] R. Haley,et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. , 1985, American journal of epidemiology.
[16] R. C. Stanley,et al. Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. , 1981, The American journal of medicine.
[17] R. Wenzel,et al. Emergence of Coagulase Negative Staphylococci as Major Nosocomial Bloodstream Pathogens , 1987, Infection Control.
[18] C. Sanders,et al. Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins. , 1988, Reviews of infectious diseases.
[19] W. Opferkuch,et al. Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein , 1987, Antimicrobial Agents and Chemotherapy.
[20] R. Haley,et al. Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. , 1985, American journal of epidemiology.
[21] K. Wilkerson,et al. Reliability of reporting nosocomial infections in the discharge abstract and implications for receipt of revenues under prospective reimbursement. , 1987, American journal of public health.
[22] C. Kunin. Evaluation of antibiotic usage: a comprehensive look at alternative approaches. , 1981, Reviews of infectious diseases.
[23] J. Quinn,et al. Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections. , 1986, The Journal of infectious diseases.
[24] J. Loeb,et al. From the Joint Commission on Accreditation of Healthcare Organizations. , 1995, JAMA.
[25] P. Hunter. Reproducibility and indices of discriminatory power of microbial typing methods , 1990, Journal of clinical microbiology.
[26] T. Holtz,et al. Postdischarge surveillance for nosocomial wound infection: a brief review and commentary. , 1992, American journal of infection control.
[27] B. Simmons,et al. Guideline for isolation precautions in hospitals , 1984, American Journal of Infection Control.
[28] M. Jackson,et al. A national task analysis of infection control practitioners, 1982. Part Two: Tasks, knowledge, and abilities for practice. , 1984, American journal of infection control.
[29] J. Mcgowan. Whence come nosocomial infections? , 1982, The New England journal of medicine.
[30] R. Haley,et al. Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. , 1981, The American journal of medicine.
[31] I. Phillips,et al. The evaluation of a typing scheme for coagulase-negative staphylococci suitable for epidemiological studies. , 1989, Journal of medical microbiology.
[32] D Draper,et al. Interpreting hospital mortality data. The role of clinical risk adjustment. , 1988, JAMA.
[33] J. Acar. Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience. , 1985, Reviews of infectious diseases.
[34] W. Williams. Guideline for infection control in hospital personnel. , 1983, Infection control : IC.
[35] R. C. Stanley,et al. The infection control nurse in US hospitals, 1976-1977. Characteristics of the position and its occupant. , 1980, American journal of epidemiology.
[36] J. Mcgowan. The Role of the Laboratory in Control of Nosocomial Infection , 1984, Infection Control.
[37] W. Noble,et al. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. , 1992, FEMS microbiology letters.
[38] J Genest,et al. [The quality of medical care]. , 1971, L'union medicale du Canada.
[39] D. Rimland,et al. Methicillin-resistant Staphylococcus aureus in Veterans Administration Medical Centers , 1987, Infection Control.
[40] B. Simmons. Guideline for prevention of intravascular infections , 1983 .
[41] D. Jacobsen,et al. Job analysis 1992: infection control practitioner. , 1993, American journal of infection control.
[42] F. Pérez,et al. Bacteremia due to Staphylococcus epidermidis: microbiologic, epidemiologic, clinical, and prognostic features. , 1990, Reviews of infectious diseases.
[43] D. Nadzam,et al. The Agenda for Change Development of the Joint Commission Infection Control Indicators , 1992, Infection Control & Hospital Epidemiology.
[44] R. Gaynes,et al. Methods to collect denominator data for calculating risk-adjusted nosocomial infection rates , 1993 .
[45] G. Jackson,et al. From the Infectious Diseases Society of America. Hospital epidemiology and infection control: the changing role of the specialist in infectious diseases. , 1981, The Journal of infectious diseases.
[46] W. Stamm. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. , 1991, The American journal of medicine.
[47] W J Martone,et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. , 1991, The American journal of medicine.
[48] R A Weinstein,et al. Epidemiology and control of nosocomial infections in adult intensive care units. , 1991, The American journal of medicine.
[49] I. Duncan,et al. Emergence of Gentamicin-Resistant Klebsiella in a General Hospital , 1977, Antimicrobial Agents and Chemotherapy.
[50] W J Martone,et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. , 1992, Infection control and hospital epidemiology.
[51] J. Boyce,et al. Increasing Occurrence of Methicillin-Resistant Staphylococcus aureus in the United States , 1982, Infection Control.
[52] H. Chambers,et al. Treatment of infection and colonization caused by methicillin-resistant Staphylococcus aureus. , 1991, Infection control and hospital epidemiology.
[53] R. Gaynes,et al. Resistance to Imipenem Among Selected Gram-Negative Bacilli in the United States , 1992, Infection Control & Hospital Epidemiology.
[54] E. Houang,et al. Aminoglycoside cross-resistance patterns of gentamicin-resistant bacteria. , 1977, Journal of clinical pathology.
[55] P. M. Terry,et al. Nosocomial infections with gentamicin-resistant Staphylococcus aureus: plamid analysis as an epidemiologic tool. , 1979, The Journal of infectious diseases.
[56] Recommendations for prevention of HIV transmission in health-care settings. , 1988, Canadian journal of medical technology.
[57] W. Scheckler,et al. Continuous Quality Improvement in a Hospital System: Implications for Hospital Epidemiology , 1992, Infection Control & Hospital Epidemiology.
[58] D. Craven,et al. Preventing nosocomial pneumonia: state of the art and perspectives for the 1990s. , 1991, The American journal of medicine.
[59] H. Nikaido,et al. Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa , 1990, Antimicrobial Agents and Chemotherapy.
[60] J. Hughes,et al. The financial incentive for hospitals to prevent nosocomial infections under the prospective payment system. An empirical determination from a nationally representative sample. , 1987, JAMA.
[61] J M Hughes,et al. CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.
[62] W J Martone,et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. , 1991, American journal of infection control.
[63] S. Cole,et al. Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae , 1989, Antimicrobial Agents and Chemotherapy.
[64] R. Gaynes,et al. Major trends in the microbial etiology of nosocomial infection. , 1991, The American journal of medicine.
[65] D. Goldmann. Nosocomial infection control in the United States of America. , 1986, The Journal of hospital infection.
[66] R. Wenzel,et al. Hospital-acquired infections. I. Surveillance in a university hospital. , 1976, American journal of epidemiology.
[67] R N Jones,et al. Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. , 1991, The American journal of medicine.
[68] H. Nikaido,et al. Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa , 1989, Antimicrobial Agents and Chemotherapy.
[69] W J Martone,et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. , 1991, The American journal of medicine.
[70] I. Phillips,et al. GENTAMICIN-RESISTANT KLEBSIELLA AEROGENES IN A UROLOGICAL WARD , 1977, The Lancet.
[71] C. E. Haley,et al. Nosocomial Legionnaires' disease: a continuing common-source epidemic at Wadsworth Medical Center. , 1979, Annals of internal medicine.
[72] B. Yangco,et al. CDC definitions for nosocomial infections. , 1989, American journal of infection control.
[73] R. Weinstein,et al. The role of the microbiology laboratory in surveillance and control of nosocomial infections. , 1978, American journal of clinical pathology.
[74] R. Haley,et al. Increased recognition of infectious diseases in US hospitals through increased use of diagnostic tests, 1970-1976. , 1985, American journal of epidemiology.
[75] J. Reading,et al. Risk factors for postoperative pneumonia. , 1981, The American journal of medicine.
[76] J. T. Crawford,et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. , 1992, The New England journal of medicine.
[77] J. Hughes,et al. Nosocomial infection surveillance, 1980-1982. , 1983, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.
[78] S. Matsumiya,et al. Severity of underlying disease as a predictor of nosocomial infection. Utility in the control of nosocomial infection. , 1978, JAMA.
[79] T. Eickhoff. The social evolution of the Infectious Diseases Society of America. , 1985, The Journal of infectious diseases.
[80] H. Elder,et al. Nosocomial infection surveillance. , 1979, QRB. Quality review bulletin.
[81] A. Cross,et al. Role of respiratory assistance devices in endemic nosocomial pneumonia. , 1981, The American journal of medicine.
[82] M. Finland. And the walls come tumbling down. More antibiotic resistance, and now the pneumococcus. , 1978, The New England journal of medicine.
[83] J. Miller,et al. Molecular technology for hospital epidemiology. , 1993, Diagnostic microbiology and infectious disease.
[84] M. Decker,et al. Continuous Quality Improvement , 1992, Infection Control & Hospital Epidemiology.
[85] D. Battista. The health care industry--where is it taking us? , 1992, The New England journal of medicine.
[86] P. Gross. Striving for benchmark infection rates: progress in control for patient mix. , 1991, The American journal of medicine.
[87] W. Jarvis,et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. , 1995, American journal of infection control.
[88] E. Wong,et al. Guideline for Prevention of Nosocomial Pneumonia , 1982, Infection Control.
[89] G. Mallison,et al. Handwashing practices for the prevention of nosocomial infections. , 1976, Annals of internal medicine.
[90] J. Rullán,et al. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. , 1992, JAMA.
[91] R. Weinstein,et al. Comparison of endemic and epidemic nosocomial infections. , 1981, The American journal of medicine.
[92] J. Duval,et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. , 1988, The New England journal of medicine.
[93] P. Gross,et al. Surveillance for Nosocomial Infections: Can the Sources of Data Be Reduced? , 1980, Infection Control.
[94] C. Kunin,et al. Prevention of catheter-induced urinary-tract infections by sterile closed drainage. , 1967, The New England journal of medicine.
[95] D. Ellis. The Joint Commission on Accreditation of Hospitals. , 1982, American College of Physicians observer.
[96] P. Gilligan,et al. Emergence of vancomycin resistance in coagulase-negative staphylococci. , 1987, The New England journal of medicine.
[97] R. Haley,et al. Microbiologic sampling of the inanimate environment in U.S. hospitals, 1976-1977. , 1981, The American journal of medicine.
[98] B. Simmons. Guideline for Prevention of Surgical Wound Infections , 1982, Infection Control & Hospital Epidemiology.
[99] W. Sudderth,et al. Incidence and prevalence as used in the analysis of the occurrence of nosocomial infections. , 1981, American journal of epidemiology.
[100] J. Mcgowan,et al. Day-specific incidence of nosocomial infection estimated from a prevalence survey. , 1981, American journal of epidemiology.
[101] G. L. French,et al. REPEATED PREVALENCE SURVEYS FOR MONITORING EFFECTIVENESS OF HOSPITAL INFECTION CONTROL , 1989, The Lancet.
[102] I. Duncan,et al. A long-term study of gentamicin-resistant Pseudomonas aeruginosa in a general hospital. , 1981, The Journal of antimicrobial chemotherapy.
[103] R. Gaynes,et al. Comparison of rates of nosocomial infections in neonatal intensive care units in the United States. National Nosocomial Infections Surveillance System. , 1991, The American journal of medicine.
[104] V L Yu,et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. , 1991, Annals of internal medicine.
[105] R. Haley. Managing Hospital Infection Control for Cost-Effectiveness , 1986 .
[106] R. Wenzel,et al. Infection control: the premier quality assessment program in United States hospitals. , 1991, The American journal of medicine.
[107] R. Weinstein,et al. Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms. , 1980, The Journal of infectious diseases.
[108] W. Rutala. Cost-effective application of the Centers for Disease Control Guideline for Handwashing and Hospital Environmental Control. , 1985, American journal of infection control.
[109] B. Burdette. Infection control in the hospital. , 1972, The Weather vane.
[110] R. Wenzel,et al. Identification of procedure-related nosocomial infections in high-risk patients. , 1981, Reviews of infectious diseases.
[111] J. Hughes,et al. Nosocomial infection surveillance, 1984. , 1986, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.
[112] J. Mcgowan,et al. Methodologic issues in hospital epidemiology. III. Investigating the modifying effects of time and severity of underlying illness on estimates of cost of nosocomial infection. , 1984, Reviews of infectious diseases.
[113] T. Eickhoff. Hospital infection control begins with good surveillance. , 1967, Hospitals.
[114] P Sharkey,et al. The importance of severity of illness in assessing hospital mortality. , 1990, JAMA.
[115] R. Weinstein,et al. The epidemiology of Pseudomonas aeruginosa in oncology patients in a general hospital. , 1989, The Journal of infectious diseases.
[116] R. Haley,et al. The nationwide nosocomial infection rate. A new need for vital statistics. , 1985, American journal of epidemiology.
[117] D Draper,et al. Changes in sickness at admission following the introduction of the prospective payment system. , 1990, JAMA.
[118] S. Solomon,et al. Health and economic impacts of antimicrobial resistance. , 1987, Reviews of infectious diseases.
[119] Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. , 1988, New York state journal of medicine.
[120] D. Wakefield,et al. Variation in Methicillin-Resistant Staphylococcus aureus Occurrence by Geographic Location and Hospital Characteristics , 1987, Infection Control.
[121] R. Garibaldi,et al. Risk factors for postoperative infection. , 1991, The American journal of medicine.